How We Think - Neurology

These are the posts from the How we think section that have been tagged with Neurology.

To see all tags used in our posts, click here.

Are we ready for an Alzheimer’s disease-modifying treatment?

Fadi Haddadeen|27th September 2019

Millions of people across the globe have Alzheimer’s disease and currently, there is no cure. But if a new therapy entered the market today, would healthcare systems be ready for it? Customer Experience Consultant Fadi Haddadeen explores this issue by mapping the patient and neurologist journeys.

read more

Diagnosing the lag in neuropsychiatric treatments

Sana Rahim|16th July 2019

The number of mental health research programmes in larger drug firms has shrunk by 70% in the past decade. Blue Latitude Health Senior Associate Consultant Sana Rahim explores this drop in investment and explains why developing a market-orientated model is vital for making progress.

 

read more

The role of brain health in treating MS

Anna Thomasson|7th June 2019

Blue Latitude Health speaks to Professor Gavin Giovannoni, key opinion leader and Chair of Neurology, Barts and The London School of Medicine and Dentistry, about his theories on brain health, the importance of a holistic approach to MS and why digital technology is the future of effective MS care.

read more

Empowering the MS patient through shared decision making

Guest Blogger|25th April 2019

Patient advocate Trishna Bharadia explains why shared decision making is crucial for ensuring multiple sclerosis patients feel heard and empowered

read more

Downloadable Pack: Understanding Multiple Sclerosis

Blue Latitude Health, Guest Blogger|6th February 2019

Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry.

read more

Innovative approaches in the treatment of multiple sclerosis

Will Frostick|23rd January 2019

Senior Associate Consultant Will Frostick delves into the MS treatment landscape and explores some of the cutting-edge treatments on the horizon.

read more

Q&A with Dr Timothy Vollmer, leading MS Neurologist

Blue Latitude Health|11th December 2018

Blue Latitude Health sits down with key opinion leader and specialist neurologist Dr Timothy Vollmer to better understand the paradigm shift in MS treatment. He explains the challenges neurologists face when making treatment decisions, and why patients need to be treated with more efficacious drugs earlier on.

read more

Living my best life with multiple sclerosis

Guest Blogger|3rd December 2018

Multi-award-winning advocate and patient engagement champion Trishna Bharadia gives a valuable insight into life with multiple sclerosis. She explains how treatment has changed, how our healthcare systems and pharma can unite to improve quality of life for MS patients today, and why her diagnosis isn’t stopping her achieving her goals.

read more

Perspective on biotech leaders

Blue Latitude Health|27th November 2017

Seven industry trailblazers reveal the trends, challenges and opportunities they anticipate in the biotech sector, from empowering patients to deciphering big data. 

 

read more

Alzheimer's Disease eeviewing the immediate treatment horizon

Alzheimer’s disease: reviewing the immediate treatment horizon

Stuart Goodman|2nd September 2016

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.

read more